Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 23.59%136.31M | 30.54%489.41M | 29.13%132.48M | 20.69%129.14M | 35.83%117.5M | 39.93%110.29M | 34.22%374.92M | 102.59M | 107M | 86.5M |
Operating revenue | 23.59%136.31M | 30.54%489.41M | 29.13%132.48M | 20.69%129.14M | 35.83%117.5M | 39.93%110.29M | 34.22%374.92M | --102.59M | --107M | --86.5M |
Cost of revenue | 28.07%43.58M | 56.62%179.33M | 44.08%43.93M | 118.12%64.4M | 28.73%36.98M | 32.06%34.03M | 23.77%114.5M | 30.49M | 29.53M | 28.72M |
Gross profit | 21.59%92.73M | 19.07%310.08M | 22.80%88.55M | -16.44%64.74M | 39.36%80.53M | 43.75%76.26M | 39.40%260.42M | 72.11M | 77.48M | 57.78M |
Operating expense | 62.42%132.6M | 116.41%629.61M | 89.09%135.96M | 353.93%319.91M | 24.41%92.1M | 9.55%81.64M | 18.22%290.93M | 71.9M | 70.48M | 74.03M |
Selling and administrative expenses | 50.81%97.6M | 100.64%472.79M | 76.18%99.06M | 318.37%236.87M | 18.66%72.15M | 4.39%64.72M | 16.10%235.64M | --56.23M | --56.62M | --60.8M |
-Selling and marketing expense | 39.98%67.62M | 87.06%328.84M | 65.89%65.62M | 285.31%162.7M | 11.71%52.22M | 2.20%48.31M | 14.69%175.8M | --39.55M | --42.23M | --46.74M |
-General and administrative expense | 82.69%29.98M | 140.53%143.95M | 100.60%33.44M | 415.39%74.17M | 41.76%19.93M | 11.43%16.41M | 20.46%59.85M | --16.67M | --14.39M | --14.06M |
Research and development costs | 106.82%35M | 183.62%156.81M | 135.38%36.9M | 499.18%83.04M | 50.85%19.95M | 35.08%16.92M | 28.19%55.29M | --15.68M | --13.86M | --13.23M |
Operating profit | -641.13%-39.87M | -947.22%-319.53M | -22,891.35%-47.41M | -3,743.74%-255.17M | 28.78%-11.57M | 74.95%-5.38M | 48.53%-30.51M | 208K | 7M | -16.25M |
Net non-operating interest income expense | 262.90%5.94M | 250.76%14.25M | 335.96%5.93M | 343.25%5.02M | 58.80%1.66M | 212.81%1.64M | 7,764.15%4.06M | 1.36M | 1.13M | 1.05M |
Non-operating interest income | 262.90%5.94M | ---- | ---- | 343.25%5.02M | ---- | 212.81%1.64M | ---- | ---- | --1.13M | ---- |
Total other finance cost | ---- | -250.76%-14.25M | ---- | ---- | -58.80%-1.66M | ---- | -7,764.15%-4.06M | ---- | ---- | ---1.05M |
Other net income (expense) | 289.44%1.71M | 146.76%498K | -196.50%-1.77M | 172.01%772K | 47,720.00%2.39M | 50.74%-900K | 80.53%-1.07M | 1.83M | -1.07M | 5K |
Other non- operating income (expenses) | 289.44%1.71M | 146.76%498K | -196.50%-1.77M | 172.01%772K | 47,720.00%2.39M | 50.74%-900K | 80.53%-1.07M | --1.83M | ---1.07M | --5K |
Income before tax | -594.04%-32.23M | -1,007.69%-304.78M | -1,372.95%-43.24M | -3,630.25%-249.38M | 50.52%-7.52M | 79.61%-4.64M | 57.54%-27.52M | 3.4M | 7.06M | -15.2M |
Income tax | 33.33%420K | 32.56%1.88M | 95.51%1.26M | -110.67%-32K | 89.14%331K | 6.78%315K | 114.87%1.42M | 646K | 300K | 175K |
Net income | -558.42%-32.65M | -959.97%-306.66M | -1,717.78%-44.51M | -3,786.35%-249.35M | 48.93%-7.85M | 78.51%-4.96M | 55.81%-28.93M | 2.75M | 6.76M | -15.37M |
Net income continuous Operations | -558.42%-32.65M | -959.97%-306.66M | -1,717.78%-44.51M | -3,786.35%-249.35M | 48.93%-7.85M | 78.51%-4.96M | 55.81%-28.93M | --2.75M | --6.76M | ---15.37M |
Minority interest income | -8.64M | -90.46M | -13.06M | -77.4M | 0 | 0 | 0 | 0 | ||
Net income attributable to the parent company | -384.29%-24.02M | -647.30%-216.2M | -1,243.18%-31.45M | -2,642.03%-171.94M | 48.93%-7.85M | 78.51%-4.96M | 55.81%-28.93M | 2.75M | 6.76M | -15.37M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -384.29%-24.02M | -647.30%-216.2M | -1,243.18%-31.45M | -2,642.03%-171.94M | 48.93%-7.85M | 78.51%-4.96M | 55.81%-28.93M | 2.75M | 6.76M | -15.37M |
Basic earnings per share | -342.06%-0.14 | -565.70%-1.23 | -1,181.45%-0.19 | -2,553.82%-1.06 | 48.93%-0.0501 | 78.51%-0.0317 | 55.81%-0.1848 | 0.0176 | 0.0432 | -0.0982 |
Diluted earnings per share | -342.06%-0.14 | -576.53%-1.25 | -1,181.45%-0.19 | -2,553.82%-1.06 | 48.93%-0.0501 | 78.51%-0.0317 | 55.81%-0.1848 | 0.0176 | 0.0432 | -0.0982 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |